Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Study Phase:
Other
Recruitment Status:
Trial Completed
Study Drug(s):
Not Applicable
Number of Participants Being Recruited:
45
Single / Multi-Center:
Single Center
STUDY BACKGROUND INFORMATION:
Neutrophils respond to areas in the body to kill foreign bacteria. They are thought to be a cause for the acute and chronic inflammation in the lungs of patients with Cystic Fibrosis. This study will look at changes in neutrophils to determine what effect they may have in exacerbations.
ELIGIBILITY
Age:
>= 7 Years
FEV1:
Not Applicable
P. aeruginosa status:
Not applicable
B. cepacia status:
Not applicable
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.
CA
Stanford University Medical Center (Pediatric), Palo Alto, CA, 94304
Contact Information:
Dunn, Colleen Phone: (650) 736-0388 Email: cedunn@stanford.edu
